Login
IBM Share Price Up 8.5% From October Low: Q3 Earnings Loom and What It Means for IBM CFD Traders
Vantage Editorial Team >
Vantage Editorial Team >
Vantage is a global, multi-asset broker with a team of in-house writers and market analysts who produce educational and insightful trading content for traders of all levels.
Updated Wed, 2026 October 21 02:43
Key Takeaways
- IBM stock closed the last hourly bar at $236.44, about 8.5% above its 8 October low near $218.
- Q3 results land 21 October at 17:00 (ET), 05:00 (GMT+8) on 22 October. Consensus is $2.85 per share on $16.82B of revenue.[1,2]
- The 50-period average (230.43) sat just under the 200-period (230.66), and the RSI read 64.88.
IBM stock traded at $236.44 as of 17:00 (GMT+8) on 20 October 2026, about 8.5% above its 8 October low. Results land 21 October after the NYSE close; consensus implies roughly 3% revenue growth against the 4% to 5% constant-currency full-year guide set in July.
IBM stock traded near $236 on 20 October 2026, 36 hours before International Business Machines Corporation (NYSE: IBM) reports third-quarter results. Prices here come from the TradingView hourly chart used for this analysis, stamped 09:00 (UTC) / 17:00 (GMT+8). The chart has handed in its homework early. The exam is Wednesday after the close.
As of 09:00 (UTC) / 17:00 (GMT+8) on 20 October 2026, IBM shares traded at $236.44 on the last hourly bar, down 0.44% on that bar, with a pre-market print of $236.29, per the TradingView chart.
A stock 8.5% above its low, facing a quarter where consensus implies about 3% revenue growth, leaves a gap. This IBM stock analysis covers the chart, the July reset, and what changes the risk picture.
Rally holds where the last one faded
The IBM share price has run this play before. On 1 October it spiked to an hourly high near $234 as Accenture’s outlook lifted IT services peers, with IBM up 5% in trading, per Vantage market news. Then it gave the gain back and bottomed near $218 on 8 October. This time price kept climbing, to hourly highs near $238 on 19 and 20 October.
The 50-period average (230.43) rose from near $222 toward the 200-period average (230.66), which has drifted lower. Both count hourly bars, not days, so they are not the 50-day and 200-day moving averages many traders quote. Price gapped above both at the 13 October open, a day after the Nasdaq closed 0.44% lower, dipped under them on 15 October (hourly low near $226), and has mostly stayed above since. The lines sit $0.23 apart, so no crossover has printed.
The RSI (14) read 64.88 against a signal line at 61.40, per the TradingView setup used for this analysis, after pushing above 70 on 13 and 19 October. That is warm, not hot: Vantage’s NVDA piece logged an RSI of 78 for that stock in September. Price and momentum rose together, so this technical analysis shows no divergence.
The IBM stock chart shows where the price sits. It cannot say what the market is waiting for.
| Level | Zone | Chart reference |
| Level 2 resistance | Near 251.70 | Mid-September swing high (14 to 16 September) |
| Level 1 resistance | Around 238 | Hourly highs on 19 and 20 October |
| Reference | 236.44 / 236.29 | Last hourly bar / pre-market print |
| Level 1 support | 230.43 to 230.66 | 50-period and 200-period moving averages |
| Level 2 support | Near 226 to 228 | Hourly lows on 14 and 15 October |
| Level 3 support | Near 218 | Swing low on 8 October |
Table 1: IBM levels traders are watching, as of 09:00 (UTC) / 17:00 (GMT+8) on 20 October 2026
Table 1 source: TradingView setup used for this analysis. Levels are chart readings, indicative only, and are not trade signals.
Q2’s 1% growth meets a 4% to 5% guide
IBM reports at 17:00 (ET) on 21 October.[1] Consensus from MarketBeat sits at $2.85 per share on $16.82B of revenue, against $2.65 and $16.33B a year ago, which works out to about 7.5% earnings growth and 3.0% revenue growth.[2] Three lines carry the read.
Software first: Q2 revenue of $7.8B rose 5%, with Hybrid Cloud up 11% and Transaction Processing down 8%.[3,5] Infrastructure second: $3.8B, down 7%, with IBM Z down 42%.[5] Guidance third: 4% to 5% constant-currency revenue growth for 2026, and free cash flow about $1B higher.[3] IBM’s 14 July investor letter pointed to late-June client spending shifting toward servers, storage, and memory, plus large deals that slipped.[4]
Now the Turn. Q2 revenue grew 1%. The full-year guide says 4% to 5%. Consensus for Q3 says about 3%. The comparison is rough, because guidance uses constant currency and consensus uses reported figures, but the shares rose 8.5% into that gap anyway.
IBM shares are up about 8.5% from the October low; Q2 revenue grew 1% against a 4% to 5% full-year guide.
Two analyst reads frame it similarly. Bank of America analyst Wamsi Mohan titled a 15 October preview “Modestly better 3Q but 4Q has to carry the year”.[7] Futurum Research, reviewing Q2, called the mainframe risk “uneven timing in how clients fund hardware, software, and capacity upgrades”, not rapid displacement.[8] Neither quote mentions a price. Both talk about timing.
That is the exam. Here is the calendar and the checklist.
Checklist for the 21 October release
- IBM results and webcast, 21 October: 17:00 (ET), 21:00 (UTC), 05:00 (GMT+8) on 22 October.[1]
- First NYSE session after results, 22 October: 09:30 (ET), 21:30 (GMT+8). Extended trading can reprice the shares before then.
- Software growth against Q2’s 5%
- Infrastructure against Q2’s 7% decline, IBM Z included
- Any change to the 4% to 5% revenue range
- Free cash flow against the roughly $1B full-year increase
- Revenue against the $16.82B consensus
The IBM news that sits outside the quarter is the 7 October move into Stage C of the DARPA Quantum Benchmarking Initiative, which is roadmap context, since the release reports Software, Consulting, and Infrastructure.[3,6] The Vantage guide to earnings season explains how results gaps work, and for IBM stock news through the week, earnings news today tracks the rest of the week. Netflix reports on 20 October after the US close, the day before IBM: see the S&P 500 note and our Netflix piece.
The read of price above the averages weakens if hourly closes return below 230.43 to 230.66. The read of resistance near $238 is challenged if hourly closes print above it.
Back to the homework: the chart submitted an 8.5% rebound early, and Wednesday is the marking. Whether 1% growth starts moving toward 4% to 5% lands at 05:00 (GMT+8) on 22 October.
For anyone holding share CFD exposure on IBM, a result after the NYSE close means the first tradable price can differ from the last close. A Stop Loss is a smoke alarm, not a fire door: it can help limit a loss to a planned size, but a gap can fill the order at a worse price.
Leverage is double-edged: it magnifies losses as well as gains, and on an earnings gap the loss can exceed what a planned exit implied. Position size relative to account equity sets how much of a gap lands on the balance, and leverage multiplies it.
IBM stock FAQ
What is the IBM stock ticker?
International Business Machines Corporation trades as IBM on the New York Stock Exchange, written NYSE: IBM or NYSE IBM. Searches for nasdaq ibm stock point to the same shares, since IBM is not listed on the Nasdaq. The IBM stock ticker is identical for IBM Corp stock, IBM Corporation stock, IBM’s stock, stock for IBM, stock of IBM, and IBM IBM stock.
What is the IBM stock price today per share?
The IBM stock price today per share was $236.44 on the last hourly bar at 17:00 (GMT+8) on 20 October 2026, a pre-market print of $236.29 alongside. That is the IBM stock price USD figure for one IBM share. An IBM stock market price, IBM stock price live, IBM stock now, IBM stocks today, IBM stock rate, or IBM stock data reading needs the NYSE feed, because this page is a snapshot.
When is the IBM earnings date, and what is IBM market cap?
The IBM earnings date is 21 October 2026, release and webcast at 17:00 (ET), 05:00 (GMT+8) on 22 October.[1] IBM market cap is the share price times shares outstanding, a count IBM reports in its filings, so it moves with the price.
Why is there no IBM forecast or recommendation here?
Searches for IBM stock price prediction 2026, IBM stock forecast, IBM stock target price, IBM stock recommendation, and is IBM stock a good buy ask for a view on direction. Vantage does not forecast prices or recommend trades, so this page covers the chart, the dated catalysts, and the risk. Related searches such as IBM stocks, IBM stocks price, and IBM stock share price are answered by the figures above.
RISK WARNING: CFDs are complex financial instruments and carry a high risk of losing money rapidly due to leverage. You should ensure you fully understand the risks involved and carefully consider whether you can afford to take the high risk of losing your money before trading.
Disclaimer: The information is provided for educational purposes only and doesn’t take into account your personal objectives, financial circumstances, or needs. It does not constitute investment advice. We encourage you to seek independent advice if necessary. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research. No representation or warranty is given as to the accuracy or completeness of any information contained within. This material may contain historical or past performance figures and should not be relied on. Furthermore estimates, forward-looking statements, and forecasts cannot be guaranteed. The information on this site and the products and services offered are not intended for distribution to any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
References
[1] “IBM to Announce Third-Quarter 2026 Financial Results – IBM Newsroom” https://newsroom.ibm.com/2026-10-07-ibm-to-announce-third-quarter-2026-financial-results Accessed on 20 October 2026.
[2] “International Business Machines (IBM) Q3 2026 Earnings Date, Time and Estimates – MarketBeat” https://www.marketbeat.com/earnings/reports/2026-10-21-international-business-machines-co-stock/ Accessed on 20 October 2026.
[3] “IBM Releases Second-Quarter Results – IBM Newsroom” https://newsroom.ibm.com/2026-07-22-IBM-RELEASES-SECOND-QUARTER-RESULTS Accessed on 20 October 2026.
[4] “Arvind Krishna’s Letter to IBM Investors – IBM Newsroom” https://newsroom.ibm.com/2026-07-14-Arvind-Krishnas-Letter-to-IBM-Investors Accessed on 20 October 2026.
[5] “IBM Releases Second-Quarter Results, Exhibit 99.1 – SEC EDGAR” https://www.sec.gov/Archives/edgar/data/51143/000005114326000077/ibm-20260722xex991.htm Accessed on 20 October 2026.
[6] “IBM Advances to Stage C of DARPA Quantum Benchmarking Initiative – IBM Newsroom” https://newsroom.ibm.com/2026-10-07-ibm-advances-to-stage-c-of-darpa-quantum-benchmarking-initiative Accessed on 20 October 2026.
[7] “IBM spent $11 billion on growth as its own software stalls – TheStreet (Bank of America note title, 15 October 2026)” https://www.thestreet.com/investing/ibm-q3-earnings-bofa-analyst-rating Accessed on 20 October 2026.
[8] “IBM Q2 FY 2026: Software Growth Continues as Mainframe Purchases Slow – Futurum” https://futurumgroup.com/insights/ibm-q2-fy-2026-software-growth-continues-as-mainframe-purchases-slow/ Accessed on 20 October 2026.
The information has been prepared as of the date published and is subject to change thereafter. The information is provided for educational purposes only and doesn't take into account your personal objectives, financial circumstances, or needs. It does not constitute investment advice. We encourage you to seek independent advice if necessary. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research. No representation or warranty is given as to the accuracy or completeness of any information contained within. This material may contain historical or past performance figures and should not be relied on. Furthermore estimates, forward-looking statements, and forecasts cannot be guaranteed. The information on this site and the products and services offered are not intended for distribution to any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
